Mark Ragosa, CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 12,000 shares at $20.00 ($240K) on 2024-01-03, disclosed to the SEC on 2024-01-04.
Scheduled sale ($240k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KNSA | SELL | 2026-01-09 | $503K | — | Filing → |
| KNSA | SELL | 2025-12-10 | $3.6M | — | Filing → |
| KNSA | SELL | 2025-11-14 | $815K | — | Filing → |